Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 21 studies | 34% ± 17% | |
oligodendrocyte | 15 studies | 39% ± 15% | |
oligodendrocyte precursor cell | 15 studies | 59% ± 22% | |
astrocyte | 14 studies | 32% ± 16% | |
glutamatergic neuron | 12 studies | 50% ± 24% | |
macrophage | 12 studies | 30% ± 14% | |
endothelial cell of lymphatic vessel | 11 studies | 47% ± 21% | |
microglial cell | 11 studies | 41% ± 9% | |
GABAergic neuron | 8 studies | 49% ± 20% | |
fibroblast | 7 studies | 29% ± 14% | |
smooth muscle cell | 6 studies | 23% ± 7% | |
amacrine cell | 6 studies | 39% ± 21% | |
retina horizontal cell | 6 studies | 45% ± 22% | |
interneuron | 5 studies | 47% ± 20% | |
retinal ganglion cell | 5 studies | 21% ± 6% | |
granule cell | 4 studies | 34% ± 6% | |
cardiac muscle cell | 4 studies | 29% ± 3% | |
myeloid cell | 4 studies | 23% ± 3% | |
neuron | 3 studies | 41% ± 20% | |
GABAergic interneuron | 3 studies | 30% ± 7% | |
GABAergic amacrine cell | 3 studies | 39% ± 10% | |
lymphocyte | 3 studies | 20% ± 2% | |
cholangiocyte | 3 studies | 54% ± 25% | |
hepatocyte | 3 studies | 55% ± 27% | |
ependymal cell | 3 studies | 43% ± 18% | |
epithelial cell | 3 studies | 25% ± 8% | |
pericyte | 3 studies | 16% ± 1% | |
mesothelial cell | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2431.61 | 2640 / 2642 | 100% | 14.53 | 704 / 705 |
prostate | 100% | 1768.95 | 245 / 245 | 97% | 7.00 | 485 / 502 |
liver | 100% | 1237.00 | 226 / 226 | 93% | 6.07 | 379 / 406 |
intestine | 100% | 919.03 | 966 / 966 | 92% | 4.20 | 487 / 527 |
pancreas | 95% | 440.81 | 310 / 328 | 96% | 5.88 | 171 / 178 |
stomach | 99% | 678.20 | 354 / 359 | 91% | 4.61 | 260 / 286 |
adrenal gland | 100% | 707.55 | 258 / 258 | 84% | 4.38 | 194 / 230 |
uterus | 100% | 3594.91 | 170 / 170 | 82% | 4.57 | 376 / 459 |
kidney | 100% | 1355.61 | 89 / 89 | 81% | 4.65 | 730 / 901 |
esophagus | 97% | 627.57 | 1401 / 1445 | 84% | 4.22 | 153 / 183 |
skin | 85% | 494.58 | 1540 / 1809 | 95% | 6.92 | 450 / 472 |
breast | 100% | 774.49 | 458 / 459 | 77% | 3.11 | 856 / 1118 |
bladder | 100% | 1007.10 | 21 / 21 | 72% | 3.15 | 363 / 504 |
lung | 100% | 1355.43 | 576 / 578 | 65% | 2.58 | 756 / 1155 |
ovary | 100% | 620.26 | 180 / 180 | 65% | 2.77 | 279 / 430 |
thymus | 100% | 899.68 | 650 / 653 | 48% | 1.59 | 292 / 605 |
spleen | 100% | 1216.67 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.16 | 1 / 1 |
blood vessel | 100% | 1132.73 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 838.69 | 1199 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 999.89 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 4.90 | 27 / 29 |
muscle | 93% | 464.00 | 747 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 3.04 | 41 / 45 |
eye | 0% | 0 | 0 / 0 | 81% | 3.97 | 65 / 80 |
peripheral blood | 30% | 248.43 | 281 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018345 | Biological process | protein palmitoylation |
GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
Gene name | ZDHHC14 |
Protein name | Zinc finger, DHHC-type containing 14, isoform CRA_f (cDNA FLJ35061 fis, clone OCBBF2018934, highly similar to Probable palmitoyltransferase ZDHHC14) (cDNA FLJ42582 fis, clone BRACE3008772, highly similar to Probable palmitoyltransferase ZDHHC14) Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14) Palmitoyltransferase (EC 2.3.1.225) |
Synonyms | hCG_17403 |
Description | FUNCTION: Palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates. May have a palmitoyltransferase activity toward the beta-2 adrenergic receptor/ADRB2 and thereby regulate G protein-coupled receptor signaling . May play a role in cell differentiation and apoptosis . . |
Accessions | H0YAX0 Q8IZN3 H0Y2Y4 ENST00000359775.10 [Q8IZN3-1] ENST00000340347.7 ENST00000518214.5 A4FVA9 ENST00000414563.6 [Q8IZN3-2] B3KRY1 |